Matrix is a national research Centre, and the clinical network consists of fifteen hospitals with cancer departments that represent all the four health regions in Norway.
InPreD – a national network for precision diagnostics. This infrastructure includes all six university hospitals in Norway that use advanced molecular diagnostics, which are subsequently reimbursed by the public healthcare system.
IMPRESS-Norway – a national researcher-initiated clinical trial opened in April 2021, which contributes to targeted cancer treatment based on precision diagnostics. The study is open to patients who have an advanced cancer where there is no longer a well-established treatment alternative. Altogether, 17 hospitals in Norway with cancer departments participate in this trial.
CONNECT – a public-private partnership driving the implementation of precision cancer medicine in Norway.
INSIGHT-INCLUDE – a cluster which, among other things, looks at health economics and reimbursement models, ethics, statistics, legal aspects and management in relation to precision medicine in cancer treatment.
Matrix will also work closely with the two new proton centers in Oslo and Bergen when these are ready for use (tentatively from 2024).